Evidence map›Paper›PMID 41463312›Full record

ReviewBiomolecules2025

Hyaluronic Acid in Topical Applications: The Various Forms and Biological Effects of a Hero Molecule in the Cosmetics Industry.

Catherine Zanchetta, Amandine Scandolera, Romain Reynaud

Abstract readReview
In one paragraph

Review in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Molecular Targets in Modern Cosmetic Science.Molecules (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Molecules (Basel, Switzerland) · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Catherine ZanchettaScience and Technology, Givaudan France SAS, 31520 Ramonville Saint Agne, France.ORCID 0000-0002-7307-3097
Amandine ScandoleraScience and Technology, Givaudan France SAS, 51110 Pomacle, France.ORCID 0000-0001-6403-1664
Romain ReynaudScience and Technology, Givaudan France SAS, 31520 Ramonville Saint Agne, France.ORCID 0000-0001-5417-5357

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHyaluronan, or hyaluronic acid (HA), is a glycosaminoglycan with structural and signaling functions playing key roles in human skin homeostasis. It ensures hydration and biomechanical properties of this tissue as well as regulates cell adhesion, migration, proliferation, and inflammation. Its biocompatibility, viscoelastic properties, biological functions, and large-scale sustainable bioproduction made this polysaccharide a hero molecule of the cosmetic industry.

methodsA literature search was conducted to discuss the skin and hair benefits of the external use of HA and its derivatives. Four main questions were addressed: What are the different forms of HA in cosmetic formulations? What about their safety? Does HA penetrate human skin and hair? What are the benefits and mode of actions of HA, and its derivatives, in the fields of cosmetic and dermatology?

resultsThe analysis revealed HA below 100 kDa to penetrate skin, and lower molecular weight being able to reach the dermis. The safety of HA-containing formulations has been evaluated in several clinical trials and is supported by independent reports of commercial ingredients. We described HA molecules having beneficial effects on skin and hair, as well as their mode of action.

conclusionsThis review provides comprehensive information on the nature and efficacy of topical HA, and its derivatives, in cosmetic applications, with an emphasis on hair care. New areas of research were highlighted as the vectorization of high-molecular-weight HA.

Indexed as

CosmeticsHyaluronic AcidAdministration, TopicalAnimalsHairHumansSkinCosmeticsHyaluronic Acidagingcosmetichuman skinhyaluronanpenetrationsafety

Identifiers

PMID41463312
PMCPMC12731180

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.